Equibles does not estimate personal net worth.
Get an email with a short summary when Caris Life Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get CAI alertsRuss Denton has spoken on 3 earnings calls across 1 company, most recently for Caris Life Sciences, Inc. on November 4, 2026. Caris Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caris Life Sciences, Inc. includes David Dean Halbert (CEO), Jeffrey Vacirca (CEO), Brian J. Brille (Chairman) and 6 others.
“Sciences released financial results for the quarter ended September 30, 2026. Joining from CARES today are David Dean Holbert, our founder, chairman, and CEO, David Spetzler, our president, Brian Rilley, our vice chairman and EVP, and Luke Power, our CFO.”
“Earlier today, Karis Life Sciences released financial results for the quarter ended June 30, 2026. Joining from CARES today are David Dean Holbert, our Founder, Chairman, and CEO, David Spetzler, our President, Brian Brilly, our Vice Chairman and EVP, and Luke Power, our CFO.”
“Earlier today, Keras Life Sciences released financial results for the quarter ended March 31, 2026. Joining from Keras today are David Dean Halbert, our founder, chairman, and CEO.”
Source not stated
Biotechnology · Healthcare
